Research Studies: Bladder/Urothelial Cancers

A Phase 3, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Vepugratinib Combined with Enfortumab Vedotin and Pembrolizumab in Adults with Untreated Locally Advanced or Metastatic Urothelial Carcinoma with an FGFR3 Genetic Alteration – FORAGER 2
Study#: i3350
Contact Us: For information about this clinical study, Email Us.